Skip to main content
Clinical Trials/NCT03291262
NCT03291262
Unknown
Not Applicable

Survival Outcomes of Ovarian Malignancies in Chinese Population

Lei Li1 site in 1 country5,000 target enrollmentJanuary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ovarian Neoplasms
Sponsor
Lei Li
Enrollment
5000
Locations
1
Primary Endpoint
Overall survival
Last Updated
7 years ago

Overview

Brief Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary ovarian malignancies in China and relevant risk factors in a prospective cohort study.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
January 1, 2023
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Lei Li
Responsible Party
Sponsor Investigator
Principal Investigator

Lei Li

Professor

Peking Union Medical College Hospital

Eligibility Criteria

Inclusion Criteria

  • Primary ovarian malignancies.

Exclusion Criteria

  • Metastatic malignancies to ovaries.

Outcomes

Primary Outcomes

Overall survival

Time Frame: 5 years

Periods from diagnosis of ovarian cancer to death

Progression-free survival

Time Frame: 5 years

Periods from diagnosis of ovarian cancer or remission of disease to next recurrence

Study Sites (1)

Loading locations...

Similar Trials